Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Resistance Training
66%
Bariatric Surgery
51%
Frailty
47%
Sarcopenia
43%
Nonalcoholic Fatty Liver
41%
Impaired Glucose Tolerance
37%
Diabetes
30%
Body Mass Index
30%
Empagliflozin
29%
Metabolic Syndrome
29%
Caloric Intake
28%
Arm
27%
Randomized Controlled Trial
26%
Table Salt
24%
Muscle Function
24%
Resting Metabolic Rate
24%
Cohort Analysis
18%
Fat Content
17%
Functional Status
17%
Metabolic Regulation
17%
Protein Intake
17%
Sodium Excretion
16%
Type 2 Diabetes
16%
Sleeve Gastrectomy
16%
Mediterranean Diet
16%
Anthropometry
15%
Lifestyle Intervention
15%
Comorbidity
15%
Patient with Type 2 Diabetes
15%
C Reactive Protein
14%
Clinical Trial
14%
Trace Element
13%
Bioelectrical Impedance Analysis
13%
Screening Test
12%
Internal Medicine
12%
Randomized Clinical Trial
12%
Body Composition Assessment
12%
Potassium Intake
12%
Surgical Technique
12%
Hormone Therapy
12%
Cyproterone Acetate
12%
Diethylstilbestrol
12%
Bisphosphonate
12%
Frailty Index
12%
Cardiovascular Disease
12%
Health Care Cost
12%
Breast Cancer
12%
Urine Sampling
12%
Glucagon Like Peptide 1
12%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
53%
Frailty
43%
Obesity
42%
Older Adults
42%
Body Composition
40%
Weight Loss
39%
Non-alcoholic Fatty Liver Disease (NAFLD)
33%
Body Mass Index
32%
National Survey
30%
Metabolic Syndrome
28%
Randomized Controlled Trial
28%
Pre-diabetes (pre-DM)
28%
Clinical Outcomes
26%
Israel
25%
Circuit Exercise
24%
Sleeve Gastrectomy
24%
Metabolic Syndrome Components
24%
Muscle Function
24%
Lifestyle Modification
24%
Bariatric Surgery
22%
Sarcopenia
22%
Diabetes
19%
Protein Intake
18%
Laparoscopic Sleeve Gastrectomy
18%
Sodium Excretion
18%
Fat Content
18%
Waist Circumference
18%
Sodium Intake
16%
High Salt Intake
16%
Hypertension
16%
Health Status
15%
Bioelectrical Impedance Analysis
15%
Israeli
14%
Metabolic Control
14%
Older Subjects
14%
Caloric Intake
14%
Metabolic Bariatric Surgery
14%
Metabolism
14%
Old Age
13%
Physical Function
13%
Sublingual
12%
Dietary Potassium
12%
Pilot Randomized Controlled Trial
12%
Gender-affirming Hormone Therapy
12%
Internal Medicine Wards
12%
Trans Women
12%
Interpersonal Variation
12%
Review Policy
12%
Type 2 Diabetic
12%
Diabetic Patients
12%